Nearly half of people with systemic sclerosis (SSc) surveyed in Australia had considered using facial cosmetic therapies, while nearly one in 4 had used at least one such treatment, a study found. Treatments were mainly considered or used to address SSc-related facial changes, and patients reported perceived improvement with nearly…
Discussion
The U.S. Food and Drug Administration (FDA) has granted fast track designation to treprostinil, an inhaled therapy to treat Raynaud’s phenomenon — a cold, numb, or prickly sensation in the fingers and toes — associated with systemic sclerosis (SSc-RP). The medication, approved under the brand name Yutrepia for the…
Discussion
Oral treatment with vitamin B3 for a couple of weeks may reduce abnormalities in tiny blood vessels of people with scleroderma who have Raynaud’s phenomenon, a small study suggests. After two weeks of supplementation, participants showed more normal and fewer giant blood vessels under the fingernails, although these…
Becoming educated and informed about scleroderma is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your scleroderma journey.
There is no cure for scleroderma yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
